Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

 

Novartis Buys Rights to Intecell's Japanese Encephalitis Vaccine Candidate

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on June 14, 2006

Novartis Buys Rights to Intecell's Japanese Encephalitis Vaccine Candidate
Novartis is buying rights to Austrian biotech firm Intercell AG's IC51 experimental vaccine against the tropical disease Japanese encephalitis. IC51 will be an addition to Novartis' portfolio of travel vaccines, which include prophylaxis against diseases such as Hepatitis A, cholera and typhoid feverlinks.

Intercell recently announced favorable results for IC51 in Phase III clinical trials and the vaccine is currently under regulatory review in Europe with an orphan drug status.

Further details from Market Watch.






Permalink: Novartis Buys Rights to Intecell's Japanese Encephalitis Vaccine Candidate
Tags: vaccine  encephalitis  biotech  novartis  rights  japanese+encephalitis  vaccine+candidate  novartis+buys 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/24761





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'


  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells